Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.
about
Vaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions.Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinaseActions of the rifamycinsPoxvirus pathogenesisAssembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicinPoxvirus membrane biogenesisDe novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infectionVaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesinAssembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacksFormation of orthopoxvirus cytoplasmic A-type inclusion bodies and embedding of virions are dynamic processes requiring microtubules.VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particlesVisualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.Vaccinia virus intracellular mature virions contain only one lipid membrane.Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions.DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane.Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesisDisulfide bonds and membrane topology of the vaccinia virus A17L envelope proteinCharacterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tailEffects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.Vaccinia virus WR gene A5L is required for morphogenesis of mature virions.The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein.Effects of a temperature sensitivity mutation in the J1R protein component of a complex required for vaccinia virus assembly.Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesiclesThe product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.Duplication of the A17L locus of vaccinia virus provides an alternate route to rifampin resistanceSimilarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D.Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusionsVaccinia virus G7L protein Interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions.Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteinsExistence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane.Lipid membranes in poxvirus replication.Rifamycins: modulation of specific anti-poxviral activity by small substitutions on the piperazinyliminomethyl side chainSynthesis of vaccinia virus polypeptides in the presence of isatin-beta-thiosemicarbazone.Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes.Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus.Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis
P2860
Q24529142-8ED2ADFF-0950-4FD4-A646-33FFE90629CCQ24607020-49CA036E-FE4D-4139-9090-110ADF415AA2Q24618138-94B5CE3E-2245-470A-AD9D-92E58DBF9FF6Q24634729-B9959995-FB62-4C37-955B-320EE8D3C6F6Q24647704-3FF154F5-2A15-444E-8297-2ED40C4C8E68Q24682102-EC37CB42-4014-46B2-89E5-D79784A1EA47Q26823774-178D895C-9B8F-4319-8F2A-2CD3FC24E434Q28541249-A6EB6489-CB90-4AE1-95D7-F21C1B66DC3FQ28576187-F8D41959-18FE-4882-AD79-7646742EC02EQ29039026-BC58CF17-F6FE-43EE-8364-4434EB80D73FQ30513986-1886A1B4-4B0C-4C8A-9B61-4500E8D2F9D6Q30731540-3F526FBF-48E0-419B-A138-A5B75779BDEFQ31905797-70372108-594D-494B-ABF4-8EF66DB51036Q33641762-5B1E5B96-784A-4AC3-A88F-AFC992A409E5Q33645823-444261BE-7134-4C80-9DE6-53B632C5411DQ33724230-1590888B-7D6B-4884-991A-97417C15050EQ33785603-E5A39D84-8300-4A5F-BD65-50B1E5CB4641Q33788819-186EA55D-224D-4EA0-98A0-7C44A08230B2Q33799135-A1791AC7-CC65-43F5-8D3B-FC4421718187Q33799254-8AE39A26-9418-43B8-9156-2C9A2CCD6489Q33809797-E72C3FFE-D3A9-4747-AE79-58E6CB806894Q33809822-9450077D-8FF4-4502-AF6C-BA92117A6A95Q33811821-F25F5468-0314-412A-9929-B8FC918C8624Q33813478-66B5AA13-F479-410B-9854-B5180515E0F9Q33834854-FE71EFE3-54E0-4DDE-89AA-C6B20746AFF4Q33843383-54BCC390-F26A-4E61-8D7D-674A4AD8315DQ33852860-DA9C69C2-70E8-4BD0-904E-A94C425EE9BAQ33930439-8C1C86AA-93C2-4CDE-B35B-64065BBB8F87Q34261794-6DC83D55-E446-436C-B802-90CDD43E19E1Q34343103-143CA940-317D-4D94-87EA-A7E9F2460AFEQ34355408-701DF016-CC6C-4048-80B2-02AAA43F8A4FQ34745104-71E39ADC-41EF-407D-BDB2-A949C1209425Q34781856-E05D0311-8807-4C25-91A6-E8B20FCFAF41Q35193307-11F51946-0DEC-4CCF-A7FE-B40A45324E3CQ35260919-CE861358-AEC0-440C-8523-0558A5D2123FQ35642888-7341C2FE-EAF3-4782-81DD-DAE9F01F73D9Q35651160-775B15CE-9609-4FC5-AA4F-67AE0519E6EEQ35784794-9648D30D-4B6D-40BA-8393-EEF071C36810Q35839800-1B868A32-F9E4-40AF-9A27-E5527B494163Q35844001-CF44C225-DEB6-4EF7-8D8E-3CE27D9096AE
P2860
Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1970
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interruption by Rifampin of an ...... precursors of virus envelopes.
@en
Interruption by Rifampin of an ...... precursors of virus envelopes.
@nl
type
label
Interruption by Rifampin of an ...... precursors of virus envelopes.
@en
Interruption by Rifampin of an ...... precursors of virus envelopes.
@nl
prefLabel
Interruption by Rifampin of an ...... precursors of virus envelopes.
@en
Interruption by Rifampin of an ...... precursors of virus envelopes.
@nl
P2093
P2860
P1433
P1476
Interruption by Rifampin of an ...... precursors of virus envelopes.
@en
P2093
P2860
P304
P407
P577
1970-10-01T00:00:00Z